Fentanyl in patients with high BMI or emaciatio

Not Applicable

Recruiting

• Conditions: Patients with high BMI (BMI >30 kg/m2) or weight loss (>20% below ideal body weight); obesity, weight loss

• Registration Number: JPRN-jRCT1021230025
• Lead Sponsor: Obara Shinju

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2023-09-27
• Last Update Posted: 23 April 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

(Study A)
20 patients with high BMI (BMI more than 30) and 20 patients with weight loss (more than 20 per cents below ideal body weight) undergoing scheduled surgery under general anesthesia using fentanyl (40 patients in total)
(Study B)
10 patients with high BMI (BMI more than 30 kg m2) and 10 patients with weight loss (more than 20 per cents below ideal body weight) undergoing scheduled surgery under general anesthesia using fentanyl (20 patients in total)
Ideal body weight = 22 x height (m2).

Exclusion Criteria

1. Patients who have received fentanyl prior to surgery
2. Patients with allergy to fentanyl
3. Patients with severe hepatic or renal dysfunction or severe hypoalbuminemia
4. Patients undergoing treatment for psychiatric or neurological disorders
5. Patients with severe anemia
6. Patients whose fentanyl dose is not 3 mcg in Study A

Study & Design

• Study Type: Observational
• Study Design: Not specified